Evidence map›Paper›PMID 41179783›Full record

ArticleFrontiers in public health2025

Global burden, inequality, and frontier gaps of autism spectrum disorder disability in adolescents and young adults, 1990-2021: a systematic analysis of the GBD 2021 study.

Derong Lin, Zhuangtang Shi, Zhen Hao, Xiaohua Xie, Jingya Fang, Mei Li, Weiqing Zhang, Shuxiong Luo, Aiguo Xue

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Derong LinDongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, China.
Zhuangtang ShiDongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, China.
Zhen HaoClinical Medical College of Acupuncture, Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, China.
Xiaohua XieDongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, China.
Jingya FangDongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, China.
Mei LiZhuhai Chronic Disease Prevention and Treatment Centre, Zhuhai, China.
Weiqing ZhangThe People's Hospital of Longhua, Shenzhen, China.
Shuxiong LuoDongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, China.
Aiguo XueDongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Autism spectrum disorder (ASD) ranks among the leading causes of years lived with disability in adolescence and young adulthood (AYA), yet global assessments still focus on childhood and seldom examine how national development modifies burden. Methods: We analysed Global Burden of Disease 2021 data for 204 countries and territories from 1990 to 2021. Among AYA aged 15-39 years, we extracted the age-standardised prevalence rate (ASPR) and disability-adjusted life-year rate (ASDR), stratified by sex, five-year age groups and Sociodemographic Index (SDI) quintile. Temporal trends were evaluated using the Estimated Annual Percentage Change (EAPC). Cross-country absolute and relative inequalities were quantified with the Slope Index of Inequality (SII) and Concentration Index (CIX). A half-normal stochastic frontier model defined the minimum attainable ASDR for each SDI level; country-year gaps were calculated as observed minus frontier values. Results: From 1990 to 2021, prevalent ASD cases increased from 17.52 to 24.13 million and DALYs from 3.30 to 4.55 million. Despite higher counts, global age-standardised rates changed little: in 2021 the ASPR was 811.67 per 100000 (95% UI 683.34-952.87) and ASDR 153.00 (95% UI 103.77-215.64); EAPCs were near zero. Males contributed about two-thirds of the burden (rate ratio ≈2.1). Disability rose most at ages 30-39 (+56%). A persistent SDI gradient was observed: high-SDI settings recorded ASPR 1090.72 and ASDR 205.00 versus 845.15 and 158.57 in low-SDI settings. In 2021, SII was 22.53 (95% UI 12.53-32.53) and CIX 0.04 (95% UI 0.02-0.05). Several high-income economies exceeded the frontier, while Bangladesh, Somalia and Niger lay on or below it-likely reflecting surveillance gaps rather than low burden. Conclusion: Absolute ASD disability in AYA has risen mainly from population growth and case detection, not higher per capita risk. A sustained male predominance, a renewed peak at ages 30-39, and minimal progress on inequality show that economic gains alone have not reduced burden. Expanding adult screening, vocational support and community-based interventions, alongside stronger surveillance and parent training in low-SDI settings, is required to narrow global gaps.

Indexed as

Autism Spectrum DisorderGlobal Burden of DiseaseGlobal HealthHealth Status DisparitiesPersons with DisabilitiesAdolescentAdultDisability-Adjusted Life YearsFemaleHumansMalePrevalenceSocioeconomic FactorsYoung Adultadolescents and young adultsautism spectrum disordercross-country inequalitydisability-adjusted life yearsfrontier analysis

Identifiers

PMID41179783
PMCPMC12571915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.